A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
2020 · Nature · 4,813 citations
https://doi.org/10.1038/s41586-020-2286-9
D
David E. Gordon
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
70
Papers
9.9K
Citations
23
h-index
29
i10-index
David E. Gordon is an academic researcher from Georgia Institute of Technology. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & interferon and immune responses & Computational Drug Discovery Methods. The author has an h-index of 23, co-authored 60 publications.
ORCID: 0000-0001-7954-0306Papers by this author
worksALG-2 and peflin regulate COPII targeting and secretion in response to calcium signaling
2021 · Journal of Biological Chemistry · 21 citations
https://doi.org/10.1016/j.jbc.2021.101393
Copper(I)-nitrene platform for chemoproteomic profiling of methionine
2024 · Nature Communications · 12 citations
https://doi.org/10.1038/s41467-024-48403-0
The multi-lineage transcription factor ISL1 controls cardiomyocyte cell fate through interaction with NKX2.5
2023 · Stem Cell Reports · 11 citations
https://doi.org/10.1016/j.stemcr.2023.09.014
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
2023 · iScience · 7 citations
https://doi.org/10.1016/j.isci.2023.107056
Acrolein-Mediated Conversion of Lysine to Electrophilic Heterocycles for Protein Diversification and Toxicity Profiling
2025 · Journal of the American Chemical Society · 4 citations
https://doi.org/10.1021/jacs.4c12928
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat